Genlink Pharma Solutions Private Limited - Charges

Every charge - open or closed - that lenders have registered against Genlink Pharma Solutions Private Limited, with the most recent activity…

2016-05-06 Thane, Maharashtra Active Unlisted Active Compliant
Share
View plans
GP Genlink Pharma Solutions Private Limited
Open charges
0
0.00
Closed charges
3
52.41 cr
Total
3
52.41 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 2 49.50 cr
2 Axis Bank Limited 1 2.91 cr
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100267171 Others 16 May 2019 - 03 Feb 2025 24.50 cr Closed
100228288 Axis Bank Limited 16 Nov 2018 26 Nov 2020 08 Apr 2024 2.91 cr Closed
100098319 Others 17 Mar 2017 10 Apr 2018 08 Apr 2025 25.00 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Genlink Pharma Solutions Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Genlink Pharma Solutions Private Limited (CIN: U74110MH2016PTC280765). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Genlink Pharma Solutions Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.